Smith, Salley & Associates
- SEC CIK
- 0001482012
- Latest filing
- Jul 23, 2026
JNJ holding history
Johnson & Johnson in every 13F filed by Smith, Salley & Associates, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
JNJ overviewAll 13F holders of JNJFull Q2 2026 holdings
- Shares (Q2 2026)
- 63,130
- Value
- $16.0M
- % of portfolio
- 0.7%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 63,130 | $16.0M | 0.7% | +5,296+9.2% | Added | Holders |
| Q1 2026 | 57,834 | $14.1M | 0.7% | +2,252+4.1% | Added | Holders |
| Q4 2025 | 55,582 | $11.5M | 0.6% | +4,152+8.1% | Added | Holders |
| Q3 2025 | 51,430 | $9.54M | 0.5% | +5,483+11.9% | Added | Holders |
| Q2 2025 | 45,947 | $7.02M | 0.4% | +1,469+3.3% | Added | Holders |
| Q1 2025 | 44,478 | $7.38M | 0.5% | +165+0.4% | Added | Holders |
| Q4 2024 | 44,313 | $6.41M | 0.4% | −768−1.7% | Reduced | Holders |
| Q3 2024 | 45,081 | $7.31M | 0.5% | +1,743+4.0% | Added | Holders |
| Q2 2024 | 43,338 | $6.33M | 0.5% | −216−0.5% | Reduced | Holders |
| Q1 2024 | 43,554 | $6.89M | 0.5% | −15,425−26.2% | Reduced | Holders |
| Q4 2023 | 58,979 | $9.24M | 0.6% | −1,934−3.2% | Reduced | Holders |
| Q3 2023 | 60,913 | $9.49M | 0.7% | −197−0.3% | Reduced | Holders |
| Q2 2023 | 61,110 | $10.1M | 0.7% | +341+0.6% | Added | Holders |
| Q1 2023 | 60,769 | $9.42M | 0.7% | +1,082+1.8% | Added | Holders |
| Q4 2022 | 59,687 | $10.5M | 0.9% | +9,333+18.5% | Added | Holders |
| Q3 2022 | 50,354 | $8.23M | 0.8% | +839+1.7% | Added | Holders |
| Q2 2022 | 49,515 | $8.79M | 0.8% | +5,135+11.6% | Added | Holders |
| Q1 2022 | 44,380 | $7.87M | 0.6% | +399+0.9% | Added | Holders |
| Q4 2021 | 43,981 | $7.52M | 0.5% | −250−0.6% | Reduced | Holders |
| Q3 2021 | 44,231 | $7.14M | 0.6% | +698+1.6% | Added | Holders |
| Q2 2021 | 43,533 | $7.17M | 0.6% | +391+0.9% | Added | Holders |
| Q1 2021 | 43,142 | $7.09M | 0.6% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.